KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

There are three types of diabetes: type 1 (usually childhood onset), type 2 (usually adult onset), and gestational (during ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Study conducted by NCD Risk Factor Collaboration (NCD-RisC) and WHO. Findings part of first global analysis of trends in both ...

Balancing your blood sugar and reducing the risk of health issues can be a challenge for people with diabetes when a cold or ...

Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.

The U.S. faces a critical shortage of primary care physicians, and the labor crunch is projected to get worse. | The company is working with New Mexico-based Presbyterian Healthcare Services to pilot ...

Discover the latest findings from the CDC on the growing prevalence of adult diabetes in the US, including key factors such as age, weight and education levels.

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.